Estera Phase I
Retirée du marché américain le 16 October 2023 (selon le DSLD)
Pharmanex, food supplement from the US market
Label withdrawn from the US market. Estera Phase I (Pharmanex), a food supplement without a usable barcode in DSLD, is described by its US market label, recorded on 24 March 2020. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label, entered on 24 March 2020. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 50 mg a day according to the label (at most 1 serving a day), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- À vérifier
Vitamine B6: up to 50 mg a day according to the label, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
Source: EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), limite supérieure de sécurité (UL).
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Pharmanex
- Barcode
- Not provided or invalid in DSLD
- Form
- Softgel
- One serving
- 2 softgels
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Gelatin, Glycerine, Soy Oil, Beeswax, Caramel
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin B6 | Vitamin | 50 mg |
| Evening Primrose Oil | Fat | 500 mg |
| Borage seed Oil | Fat | 250 mg |
| Chasteberry fruit (Vitex agnus/castus L.) extract | Plant | 250 mg |
| Diindolylmethane | Other substance | 100 mg |
| Pomegranate fruit (Punica granatum) extract (Punica granatum) | Plant | 40 mg |
| Lignans | Other substance | 15 mg |
| Genistein | Other substance | 10 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Estera Phase I
Entered into DSLD on 21 October 2017. Retirée du marché américain le 20 August 2019 (selon le DSLD).- Same quantity, different name: Diindolylymethane in this version; Diindolylmethane on the displayed label (100 mg)
Official label: Estera Phase I
Entered into DSLD on 25 November 2013. Retirée du marché américain le 24 August 2017 (selon le DSLD).- Same quantity, different name: Chasteberry (Vitex agnus/castus) fruit extract in this version; Chasteberry fruit (Vitex agnus/castus L.) extract on the displayed label (250 mg)
- Same quantity, different name: Diindolylymethane in this version; Diindolylmethane on the displayed label (100 mg)
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : Pharmanex